VXRT 8-K: SEC filing

Vaxart

Filed with the SEC on · accession 0001437749-26-035275

VXRT filed a 8-K (current report) with the SEC on Nov 5, 2026. Vaxart reported Q3 2026 financial results with revenue of $10.6 million (down from $72.4 million a year ago) and a net loss of $17.7 million, while announcing that topline data from its Phase 2b COVID-19 trial is now expected by mid-year 2027.

Summary of the filing

Vaxart reported Q3 2026 financial results with revenue of $10.6 million (down from $72.4 million a year ago) and a net loss of $17.7 million, while announcing that topline data from its Phase 2b COVID-19 trial is now expected by mid-year 2027. The company also disclosed $65.5 million in cash with runway into Q2 2027 and the appointment of Dr. Raquel Bono to its Board of Directors.

Key details

Q3 2026 revenue$10.6M
Q3 2025 revenue$72.4M
Q3 2026 net loss-$17.7M
Q3 2025 net loss-$8.1M
Cash, cash equivalents, and short-term investments as of September 30, 2026$65.5M
Cumulative cash payments received under BARDA contract$278.0M
Q3 2026 R&D expenses$22.8M
Q3 2025 R&D expenses$75.9M
Q3 2026 G&A expenses$5.1M
Q3 2025 G&A expenses$4.3M
IssuerVaxart, Inc.
Government contract partnerBARDA
License and collaboration partnerDynavax
Chief executive officerSteven Lo
Board directorRaquel C. Bono

✦ Ask GOAX AI about this filing — what it means for VXRT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VXRT?

Click here

Frequently asked questions

What did VXRT file with the SEC on Nov 5, 2026?

VXRT filed a 8-K (SEC filing). Vaxart reported Q3 2026 financial results with revenue of $10.6 million (down from $72.4 million a year ago) and a net loss of $17.7 million, while announcing that topline data from its Phase 2b COVID-19 trial is now expected by mid-year 2027. The company also disclosed $65.5 million in cash with runway into Q2 2027 and the appointment of Dr. Raquel Bono to its Board of Directors.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other VXRT SEC filings

Get alerts when VXRT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days